Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.
Published April 9, 2025 · Recall initiated: March 24, 2025
Summary
FDA records drug Class II recall D-0307-2025, published April 9, 2025 and initiated March 24, 2025. Recalling firm: Amerisource Health Services LLC; Status: Terminated; Reported quantity: 889 cartons; Lot: Lot # 1014138, Exp 04/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
What to do
Voluntary: Firm initiated · Letter
Get an email if VORICONAZOLE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VORICONAZOLE
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- USA nationwide.
- Lot
- Lot # 1014138, Exp 04/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVoriconazole Tablets 50mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAVoriconazole Tablets 200 mg, 30-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAAtorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc.,April 9, 2025
- FDADuloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: TowaApril 9, 2025
- FDATropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mLApril 9, 2025
- FDAVoriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions:February 28, 2024
Questions about this recall
Was Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11. recalled?
Yes. FDA published recall D-0307-2025 on April 9, 2025. Reported hazard: cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VORICONAZOLE.